trending Market Intelligence /marketintelligence/en/news-insights/trending/s614wORW7UHlZ0OqlJ-JrA2 content esgSubNav
In This List

Sanofi prices €2B debt offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Sanofi prices €2B debt offering

Sanofi has priced a €2 billion debt offering, with net proceeds to be used for general corporate purposes.

The French pharmaceutical giant is offering €850 million of zero percent fixed-rate notes due March 2022, €650 million of 0.875% fixed-rate notes due March 2029 and €500 million of 1.25% fixed-rate notes due March 2034.

Sanofi said the notes, being issued under a euro medium-term note program, will help the company lower its average cost of debt and extend the average maturity of the debt.

Bank of America Merrill Lynch and Natixis are serving as global coordinators and book runners. ING and Santander are also serving as book runners for the offering.